Choose your country

Seegene’s Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization

SEOUL, Korea, Apr 22, 2020 - Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test fo...

Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries

Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts fo...

Seegene Receives Health Canada Approval for its COVID-19 Assay

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale in Canada of Seegene's Allplex™ 2019-nCo...

How One Firm's Covid-19 Tests Help Control The Virus In South Korea

South Korea's coronavirus test makers in high demand

RAI, the national public broadcasting company of Italy, focused on the COVID-19 test kit of Seegene in an interview with the president of Arrow Diagnostics S.r.l (Seegene's subsidiary in Italy)

S. Korea to facilitate exports of COVID-19 diagnostic reagents: Moon

Virus Test-Kit Maker Meets Demand That Lifts Founder’s Fortune

CNN spotlighted “How this south Korean company created coronavirus test kits in three weeks"

Virus Testing Blitz Appears to Keep Korea Death Rate Low

Introducing Seegene COVID-19 assay on BFM TV in France : La high-tech française, arme anti-coronavirus

Seegene launches KFDA Approved COVID-19 Assay

SEOUL, Korea, Feb 18, 2020 – Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronav...

Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019

2019 American Society for Microbiology Microbe Conference: Booth #1062 SEOUL, Korea, June 21, 2019 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in So...

Seegene Establishes Brazilian Subsidiary Seegene Brazil Diagnostics LTDA to target IVD market in Latin America

SEOUL, Korea, June 18, 2019 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced today the formation of a new subsidiary, Seegene do Br...